LivaNova (LIVN) Financials

$45.51 +0.34 (+0.75%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$45.52 +0.01 (+0.01%)

As of 06/20/2025 05:45 PM Eastern

Annual Income Statements for LivaNova

This table shows LivaNova's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-86	18	63
Consolidated Net Income / (Loss)	-86	18	63
Net Income / (Loss) Continuing Operations	-86	18	63
Total Pre-Tax Income	-75	-81	88
Total Operating Income	-77	-68	129
Total Gross Profit	707	771	871
Total Revenue	1,022	1,154	1,253
Operating Revenue	1,022	1,154	1,253
Total Cost of Revenue	315	382	383
Operating Cost of Revenue	315	382	383
Total Operating Expenses	784	840	742
Selling, General & Admin Expense	469	518	526
Research & Development Expense	156	194	183
Other Operating Expenses / (Income)	30	38	33
Impairment Charge	129	90	0.00
Total Other Income / (Expense), net	1.61	-13	-41
Interest Expense	48	59	89
Other Income / (Expense), net	50	46	48
Income Tax Expense	11	-99	25
Other Gains / (Losses), net	-0.05	-0.10	-0.02
Basic Earnings per Share	($1.61)	$0.33	$1.17
Weighted Average Basic Shares Outstanding	53.47M	53.94M	54.24M
Diluted Earnings per Share	($1.61)	$0.32	$1.16
Weighted Average Diluted Shares Outstanding	53.47M	54.21M	54.57M
Weighted Average Basic & Diluted Shares Outstanding	53.56M	53.96M	54.35M

This table shows LivaNova's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-107	1.66	7.37	1.16	-7.32	16	-42	16	33	56	-327
Consolidated Net Income / (Loss)	-107	1.66	7.37	1.16	-7.32	16	-42	16	33	56	-327
Net Income / (Loss) Continuing Operations	-107	1.66	7.37	1.16	-7.32	16	-42	16	33	56	-327
Total Pre-Tax Income	-106	6.39	9.77	5.28	-1.98	-94	-34	22	44	56	-316
Total Operating Income	-132	14	-2.34	17	4.46	-88	16	40	36	37	49
Total Gross Profit	171	184	174	205	202	190	207	219	225	219	221
Total Revenue	253	275	263	294	286	310	295	319	318	322	317
Operating Revenue	253	275	263	294	286	310	295	319	318	322	317
Total Cost of Revenue	82	91	89	89	84	120	88	100	93	102	96
Operating Cost of Revenue	82	91	89	89	84	120	88	100	93	102	96
Total Operating Expenses	303	170	176	188	197	278	191	179	190	182	172
Selling, General & Admin Expense	115	120	124	126	135	133	130	129	132	136	134
Research & Development Expense	36	45	50	51	47	46	46	45	49	43	38
Other Operating Expenses / (Income)	23	5.02	2.31	11	16	8.68	16	4.84	9.18	3.40	0.61
Total Other Income / (Expense), net	26	-7.57	12	-12	-6.44	-6.31	-50	-19	8.82	19	-364
Interest Expense	13	13	13	15	15	16	41	16	16	16	15
Other Income / (Expense), net	39	5.80	26	2.71	8.55	9.32	-9.07	-3.05	25	35	-349
Income Tax Expense	1.30	4.70	2.37	4.10	5.31	-111	7.72	5.23	12	0.59	12
Other Gains / (Losses), net	0.06	-0.03	-0.03	-0.03	-0.03	-0.02	-0.03	-0.03	0.04	-	-0.02
Basic Earnings per Share	($2.01)	$0.03	$0.14	$0.02	($0.14)	$0.31	($0.78)	$0.30	$0.61	$1.04	($6.01)
Weighted Average Basic Shares Outstanding	53.53M	53.47M	53.62M	53.80M	53.99M	53.94M	54.01M	54.24M	54.35M	54.24M	54.42M
Diluted Earnings per Share	($2.01)	$0.04	$0.14	$0.02	($0.14)	$0.30	($0.78)	$0.30	$0.60	$1.04	($6.01)
Weighted Average Diluted Shares Outstanding	53.53M	53.47M	53.90M	53.98M	53.99M	54.21M	54.01M	54.59M	54.59M	54.57M	54.42M
Weighted Average Basic & Diluted Shares Outstanding	53.52M	53.56M	53.77M	53.88M	53.87M	53.96M	54.15M	54.30M	54.30M	54.35M	54.53M

This table details how cash moves in and out of LivaNova's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	308	62	146
Net Cash From Operating Activities	70	75	183
Net Cash From Continuing Operating Activities	70	75	184
Net Income / (Loss) Continuing Operations	-86	18	63
Consolidated Net Income / (Loss)	-86	18	63
Depreciation Expense	48	50	42
Amortization Expense	32	30	30
Non-Cash Adjustments To Reconcile Net Income	176	140	62
Changes in Operating Assets and Liabilities, net	-99	-163	-14
Net Cash From Investing Activities	-38	-40	-48
Net Cash From Continuing Investing Activities	-38	-40	-48
Purchase of Property, Plant & Equipment	-27	-35	-47
Acquisitions	-8.86	0.00	0.00
Purchase of Investments	-2.95	-6.50	-1.14
Other Investing Activities, net	-0.09	1.15	0.09
Net Cash From Financing Activities	280	21	19
Net Cash From Continuing Financing Activities	280	21	19
Repayment of Debt	-221	-21	-318
Repurchase of Common Equity	-3.29	0.00	-5.94
Issuance of Debt	508	50	336
Other Financing Activities, net	-3.43	-7.48	6.68
Effect of Exchange Rate Changes	-4.01	6.19	-7.75
Cash Interest Paid	19	37	39
Cash Income Taxes Paid	1.22	-1.62	16

This table details how cash moves in and out of LivaNova's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	100	9.34	7.34	11	-1.64	45	38	17	33	57	15
Net Cash From Operating Activities	36	19	21	-18	18	54	9.98	43	51	79	24
Net Cash From Continuing Operating Activities	36	19	21	-18	18	54	9.98	43	51	80	24
Net Income / (Loss) Continuing Operations	-107	1.66	7.37	1.16	-7.32	16	-42	16	33	56	-327
Consolidated Net Income / (Loss)	-107	1.66	7.37	1.16	-7.32	16	-42	16	33	56	-327
Depreciation Expense	12	12	12	12	13	12	11	10	11	11	6.42
Amortization Expense	6.83	8.07	7.66	6.98	6.87	8.18	7.44	7.13	8.04	7.82	14
Non-Cash Adjustments To Reconcile Net Income	106	51	-16	6.88	12	137	47	16	-2.74	2.28	373
Changes in Operating Assets and Liabilities, net	19	-54	9.23	-45	-6.22	-120	-13	-6.62	2.16	3.42	-42
Net Cash From Investing Activities	-5.83	-11	-11	-6.66	-10	-12	-6.36	-13	-19	-11	-11
Net Cash From Continuing Investing Activities	-5.83	-11	-11	-6.66	-10	-12	-6.36	-13	-19	-11	-11
Purchase of Property, Plant & Equipment	-6.04	-9.13	-7.69	-5.66	-8.72	-13	-6.40	-12	-18	-10	-11
Other Investing Activities, net	0.36	0.21	1.34	-0.72	-0.18	0.72	0.04	-0.04	0.10	-0.01	0.16
Net Cash From Financing Activities	73	-1.66	-5.24	36	-4.28	-5.02	37	-12	-3.28	-3.44	-4.42
Net Cash From Continuing Financing Activities	73	-1.66	-5.24	36	-4.28	-5.02	37	-12	-3.28	-3.44	-4.42
Repayment of Debt	-220	2.90	-3.66	-9.74	-3.13	-4.51	-305	-3.94	-4.45	-4.38	-4.42
Issuance of Debt	289	-	0.00	50	-	-	336	-	-	-	0.00
Other Financing Activities, net	-	-8.03	-1.58	-4.25	-1.15	-0.51	8.46	-4.13	1.40	0.95	0.00
Effect of Exchange Rate Changes	-3.53	3.25	3.30	-0.02	-5.44	8.35	-2.95	-1.48	4.26	-7.58	5.96

This table presents LivaNova's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	2,295	2,430	2,506
Total Current Assets	886	988	1,127
Cash & Equivalents	214	267	429
Restricted Cash	301	311	295
Accounts Receivable	183	215	193
Inventories, net	129	148	148
Prepaid Expenses	26	27	32
Current Deferred & Refundable Income Taxes	32	20	31
Plant, Property, & Equipment, net	147	154	170
Total Noncurrent Assets	1,261	1,287	1,209
Goodwill	769	783	750
Intangible Assets	369	261	237
Noncurrent Deferred & Refundable Income Taxes	1.38	119	112
Other Noncurrent Operating Assets	123	124	110
Total Liabilities & Shareholders' Equity	2,295	2,430	2,506
Total Liabilities	1,087	1,152	1,186
Total Current Liabilities	297	335	392
Short-Term Debt	23	18	78
Accounts Payable	74	81	70
Accrued Expenses	81	107	118
Current Deferred & Payable Income Tax Liabilities	17	23	32
Current Employee Benefit Liabilities	72	95	81
Other Current Liabilities	29	11	13
Total Noncurrent Liabilities	790	817	794
Long-Term Debt	518	569	550
Noncurrent Deferred & Payable Income Tax Liabilities	8.52	12	11
Noncurrent Employee Benefit Liabilities	17	17	13
Other Noncurrent Operating Liabilities	246	220	221
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,208	1,278	1,320
Total Preferred & Common Equity	1,208	1,278	1,320
Total Common Equity	1,208	1,278	1,320
Common Stock	2,240	2,272	2,304
Retained Earnings	-984	-966	-903
Treasury Stock	-0.38	-0.06	-0.14
Accumulated Other Comprehensive Income / (Loss)	-48	-28	-80

This table presents LivaNova's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	2,213	2,295	2,342	2,329	2,460	2,453	2,522	2,559
Total Current Assets	851	903	942	954	1,040	1,047	1,093	1,171
Cash & Equivalents	231	214	223	234	309	329	346	738
Restricted Cash	275	309	311	299	306	304	320	0.00
Accounts Receivable	172	178	186	190	209	201	197	202
Inventories, net	122	142	156	162	153	155	162	154
Prepaid Expenses	24	35	39	44	39	36	43	47
Current Deferred & Refundable Income Taxes	26	24	26	26	23	22	24	29
Plant, Property, & Equipment, net	139	149	150	149	152	158	169	178
Total Noncurrent Assets	1,222	1,243	1,250	1,226	1,267	1,248	1,260	1,210
Goodwill	742	774	779	767	772	766	782	762
Intangible Assets	365	364	357	348	254	248	249	237
Noncurrent Deferred & Refundable Income Taxes	1.42	1.53	2.11	1.51	114	113	110	109
Other Noncurrent Operating Assets	114	103	111	110	128	121	119	102
Total Liabilities & Shareholders' Equity	2,213	2,295	2,342	2,329	2,460	2,453	2,522	2,559
Total Liabilities	1,066	1,068	1,101	1,104	1,238	1,211	1,212	1,524
Total Current Liabilities	288	316	288	295	328	303	324	742
Short-Term Debt	22	22	19	19	20	20	22	80
Accounts Payable	70	76	78	63	76	81	78	88
Accrued Expenses	79	96	82	90	94	98	105	469
Current Deferred & Payable Income Tax Liabilities	12	22	20	22	30	23	27	40
Current Employee Benefit Liabilities	58	80	67	75	91	65	77	53
Other Current Liabilities	48	19	22	27	17	16	16	13
Total Noncurrent Liabilities	778	751	813	809	910	908	888	783
Long-Term Debt	518	520	568	568	605	605	604	549
Noncurrent Deferred & Payable Income Tax Liabilities	6.53	8.63	8.92	9.93	11	11	12	11
Noncurrent Employee Benefit Liabilities	18	16	17	16	17	16	15	13
Other Noncurrent Operating Liabilities	236	206	219	215	278	275	257	210
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,147	1,227	1,241	1,225	1,222	1,243	1,310	1,034
Total Preferred & Common Equity	1,147	1,227	1,241	1,225	1,222	1,243	1,310	1,034
Total Common Equity	1,147	1,227	1,241	1,225	1,222	1,243	1,310	1,034
Common Stock	2,226	2,245	2,252	2,263	2,276	2,288	2,296	2,309
Retained Earnings	-986	-977	-976	-983	-1,008	-992	-959	-1,231
Treasury Stock	-0.38	-0.32	-0.10	-0.06	-0.48	-0.20	-0.16	-1.43
Accumulated Other Comprehensive Income / (Loss)	-93	-41	-36	-55	-45	-53	-27	-43

This table displays calculated financial ratios and metrics derived from LivaNova's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	-1.31%	12.89%	8.66%
EBITDA Growth	-25.97%	10.14%	333.82%
EBIT Growth	-90.95%	16.80%	890.52%
NOPAT Growth	-9,689.80%	10.75%	292.77%
Net Income Growth	36.50%	120.34%	260.39%
EPS Growth	39.93%	119.88%	262.50%
Operating Cash Flow Growth	-31.81%	7.14%	144.33%
Free Cash Flow Firm Growth	-73.05%	-358.98%	253.21%
Invested Capital Growth	-6.99%	4.29%	-4.83%
Revenue Q/Q Growth	0.47%	3.15%	0.94%
EBITDA Q/Q Growth	39.74%	-62.97%	147.44%
EBIT Q/Q Growth	36.88%	-129.42%	581.81%
NOPAT Q/Q Growth	-16.37%	-1,034.95%	3,168.48%
Net Income Q/Q Growth	7.30%	511.79%	167.01%
EPS Q/Q Growth	5.85%	433.33%	176.19%
Operating Cash Flow Q/Q Growth	-17.45%	88.90%	15.64%
Free Cash Flow Firm Q/Q Growth	-72.66%	-7.08%	1,082.92%
Invested Capital Q/Q Growth	4.48%	0.51%	-3.57%
Profitability Metrics	-	-	-
Gross Margin	69.21%	66.86%	69.48%
EBITDA Margin	5.11%	4.99%	19.91%
Operating Margin	-7.51%	-5.94%	10.30%
EBIT Margin	-2.63%	-1.94%	14.11%
Profit (Net Income) Margin	-8.44%	1.52%	5.04%
Tax Burden Percent	114.78%	-21.60%	71.60%
Interest Burden Percent	279.42%	363.05%	49.93%
Effective Tax Rate	0.00%	0.00%	28.38%
Return on Invested Capital (ROIC)	-4.20%	-3.81%	7.36%
ROIC Less NNEP Spread (ROIC-NNEP)	-117.48%	374.07%	74.37%
Return on Net Nonoperating Assets (RNNOA)	-2.70%	5.22%	-2.49%
Return on Equity (ROE)	-6.89%	1.41%	4.87%
Cash Return on Invested Capital (CROIC)	3.04%	-8.00%	12.31%
Operating Return on Assets (OROA)	-1.20%	-0.95%	7.17%
Return on Assets (ROA)	-3.84%	0.74%	2.56%
Return on Common Equity (ROCE)	-6.89%	1.41%	4.87%
Return on Equity Simple (ROE_SIMPLE)	-7.14%	1.37%	4.79%
Net Operating Profit after Tax (NOPAT)	-54	-48	92
NOPAT Margin	-5.26%	-4.16%	7.37%
Net Nonoperating Expense Percent (NNEP)	113.28%	-377.87%	-67.01%
Return On Investment Capital (ROIC_SIMPLE)	-3.07%	-2.57%	4.75%
Cost of Revenue to Revenue	30.79%	33.14%	30.52%
SG&A Expenses to Revenue	45.92%	44.92%	41.99%
R&D to Revenue	15.25%	16.80%	14.56%
Operating Expenses to Revenue	76.73%	72.80%	59.18%
Earnings before Interest and Taxes (EBIT)	-27	-22	177
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	52	58	250
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	2.46	2.18	1.90
Price to Tangible Book Value (P/TBV)	42.30	11.94	7.55
Price to Revenue (P/Rev)	2.91	2.42	2.01
Price to Earnings (P/E)	0.00	158.86	39.77
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.63%	2.51%
Enterprise Value to Invested Capital (EV/IC)	2.43	2.17	1.98
Enterprise Value to Revenue (EV/Rev)	2.93	2.42	1.93
Enterprise Value to EBITDA (EV/EBITDA)	57.40	48.60	9.69
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	13.68
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	26.17
Enterprise Value to Operating Cash Flow (EV/OCF)	42.88	37.32	13.21
Enterprise Value to Free Cash Flow (EV/FCFF)	77.00	0.00	15.65
Leverage & Solvency	-	-	-
Debt to Equity	0.45	0.46	0.48
Long-Term Debt to Equity	0.43	0.45	0.42
Financial Leverage	0.02	0.01	-0.03
Leverage Ratio	1.80	1.90	1.90
Compound Leverage Factor	5.02	6.90	0.95
Debt to Total Capital	30.96%	31.47%	32.22%
Short-Term Debt to Total Capital	1.34%	0.97%	4.00%
Long-Term Debt to Total Capital	29.62%	30.50%	28.22%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	69.04%	68.53%	67.78%
Debt to EBITDA	10.37	10.20	2.51
Net Debt to EBITDA	0.50	0.15	-0.38
Long-Term Debt to EBITDA	9.92	9.88	2.20
Debt to NOPAT	-10.08	-12.24	6.79
Net Debt to NOPAT	-0.48	-0.18	-1.04
Long-Term Debt to NOPAT	-9.64	-11.86	5.95
Altman Z-Score	1.75	1.66	1.85
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.98	2.95	2.87
Quick Ratio	1.34	1.44	1.59
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	39	-101	155
Operating Cash Flow to CapEx	263.68%	214.16%	388.56%
Free Cash Flow to Firm to Interest Expense	0.81	-1.71	1.74
Operating Cash Flow to Interest Expense	1.45	1.27	2.07
Operating Cash Flow Less CapEx to Interest Expense	0.90	0.68	1.54
Efficiency Ratios	-	-	-
Asset Turnover	0.45	0.49	0.51
Accounts Receivable Turnover	5.55	5.79	6.14
Inventory Turnover	2.67	2.76	2.59
Fixed Asset Turnover	6.88	7.66	7.73
Accounts Payable Turnover	4.42	4.93	5.08
Days Sales Outstanding (DSO)	65.81	63.00	59.44
Days Inventory Outstanding (DIO)	136.46	132.36	140.94
Days Payable Outstanding (DPO)	82.56	74.07	71.83
Cash Conversion Cycle (CCC)	119.71	121.29	128.55
Capital & Investment Metrics	-	-	-
Invested Capital	1,234	1,286	1,224
Invested Capital Turnover	0.80	0.92	1.00
Increase / (Decrease) in Invested Capital	-93	53	-62
Enterprise Value (EV)	2,999	2,796	2,419
Market Capitalization	2,973	2,787	2,515
Book Value per Share	$22.56	$23.72	$24.31
Tangible Book Value per Share	$1.31	$4.33	$6.13
Total Capital	1,749	1,864	1,948
Total Debt	542	587	628
Total Long-Term Debt	518	569	550
Net Debt	26	8.78	-96
Capital Expenditures (CapEx)	27	35	47
Debt-free, Cash-free Net Working Capital (DFCFNWC)	97	93	90
Debt-free Net Working Capital (DFNWC)	612	671	813
Net Working Capital (NWC)	589	653	735
Net Nonoperating Expense (NNE)	33	-65	29
Net Nonoperating Obligations (NNO)	26	8.78	-96
Total Depreciation and Amortization (D&A)	79	80	73
Debt-free, Cash-free Net Working Capital to Revenue	9.45%	8.10%	7.14%
Debt-free Net Working Capital to Revenue	59.91%	58.19%	64.87%
Net Working Capital to Revenue	57.62%	56.62%	58.64%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($1.61)	$0.33	$1.17
Adjusted Weighted Average Basic Shares Outstanding	53.47M	53.94M	54.24M
Adjusted Diluted Earnings per Share	($1.61)	$0.32	$1.16
Adjusted Weighted Average Diluted Shares Outstanding	53.47M	54.21M	54.57M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.56M	53.96M	54.35M
Normalized Net Operating Profit after Tax (NOPAT)	37	15	92
Normalized NOPAT Margin	3.61%	1.30%	7.37%
Pre Tax Income Margin	-7.35%	-7.04%	7.05%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-0.56	-0.38	2.00
NOPAT to Interest Expense	-1.11	-0.81	1.04
EBIT Less CapEx to Interest Expense	-1.11	-0.97	1.47
NOPAT Less CapEx to Interest Expense	-1.66	-1.41	0.51
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-3.82%	0.00%	9.39%

This table displays calculated financial ratios and metrics derived from LivaNova's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.24%	1.78%	9.68%	15.63%	13.27%	12.83%	11.96%	8.40%	11.19%	3.77%	7.44%
EBITDA Growth	-249.50%	59.49%	32.59%	-27.98%	143.71%	-245.61%	-41.60%	38.35%	140.64%	256.46%	-1,210.55%
EBIT Growth	-411.11%	388.38%	73.06%	-39.83%	113.92%	-498.25%	-69.08%	84.78%	363.71%	191.83%	-4,286.20%
NOPAT Growth	-903.64%	-78.71%	-134.27%	-85.87%	103.38%	-1,769.29%	741.22%	681.92%	745.39%	159.48%	199.26%
Net Income Growth	-147.09%	132.40%	146.24%	-92.98%	93.18%	883.68%	-669.10%	1,314.11%	550.30%	242.07%	-680.40%
EPS Growth	-139.29%	166.67%	133.33%	-93.33%	93.03%	650.00%	-657.14%	1,400.00%	528.57%	246.67%	-670.51%
Operating Cash Flow Growth	48.78%	-44.14%	-19.62%	-75.11%	-49.11%	188.50%	-51.92%	341.71%	181.18%	45.87%	140.12%
Free Cash Flow Firm Growth	-76.89%	-40.65%	-11.40%	103.95%	-199.98%	-218.82%	-54.47%	71.76%	138.06%	186.22%	1,115.68%
Invested Capital Growth	-13.77%	-6.99%	-4.82%	-3.58%	8.41%	4.29%	-1.33%	-4.54%	-0.80%	-4.83%	-24.84%
Revenue Q/Q Growth	-0.61%	8.82%	-4.17%	11.56%	-2.64%	8.39%	-4.91%	8.02%	-0.14%	1.17%	-1.55%
EBITDA Q/Q Growth	-236.71%	153.06%	8.41%	-8.41%	-17.04%	-276.78%	143.48%	116.98%	44.30%	14.94%	-408.60%
EBIT Q/Q Growth	-379.87%	121.14%	17.46%	-13.43%	-35.25%	-704.82%	109.12%	417.37%	62.49%	19.77%	-515.74%
NOPAT Q/Q Growth	-435.29%	103.99%	-148.07%	319.51%	-19.84%	-2,073.76%	118.46%	167.68%	-13.34%	38.87%	-7.11%
Net Income Q/Q Growth	-752.79%	101.55%	343.71%	-84.33%	-733.59%	323.27%	-356.70%	138.94%	101.76%	69.61%	-685.64%
EPS Q/Q Growth	-770.00%	101.99%	250.00%	-85.71%	-800.00%	314.29%	-360.00%	138.46%	100.00%	73.33%	-677.88%
Operating Cash Flow Q/Q Growth	447.93%	-47.52%	10.98%	-186.41%	201.11%	197.52%	-81.50%	334.39%	17.62%	54.35%	-69.55%
Free Cash Flow Firm Q/Q Growth	107.32%	0.15%	-36.30%	-15.46%	-285.39%	-19.03%	124.40%	218.94%	-58.91%	169.60%	244.11%
Invested Capital Q/Q Growth	-11.98%	4.48%	1.08%	3.72%	-1.03%	0.51%	-4.36%	0.35%	2.84%	-3.57%	-24.48%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	67.66%	66.76%	66.09%	69.82%	70.53%	61.32%	70.32%	68.70%	70.81%	68.16%	69.68%
EBITDA Margin	-29.71%	14.49%	16.39%	13.46%	11.47%	-18.70%	8.55%	17.17%	24.82%	28.19%	-88.37%
Operating Margin	-52.24%	5.08%	-0.89%	5.91%	1.56%	-28.37%	5.51%	12.61%	11.20%	11.50%	15.34%
EBIT Margin	-36.99%	7.19%	8.81%	6.84%	4.55%	-25.37%	2.43%	11.65%	18.96%	22.45%	-94.79%
Profit (Net Income) Margin	-42.49%	0.60%	2.80%	0.39%	-2.56%	5.27%	-14.22%	5.13%	10.36%	17.37%	-103.30%
Tax Burden Percent	101.17%	25.98%	75.45%	21.88%	369.97%	-17.33%	122.64%	75.65%	74.15%	98.96%	103.70%
Interest Burden Percent	113.55%	32.37%	42.09%	26.28%	-15.21%	119.86%	-476.66%	58.16%	73.68%	78.18%	105.09%
Effective Tax Rate	0.00%	73.57%	24.27%	77.59%	0.00%	0.00%	0.00%	24.21%	25.93%	1.04%	0.00%
Return on Invested Capital (ROIC)	-29.17%	1.07%	-0.55%	1.09%	0.99%	-18.18%	3.69%	9.15%	8.08%	11.37%	12.71%
ROIC Less NNEP Spread (ROIC-NNEP)	-62.28%	-6.00%	47.93%	-3.80%	-22.70%	431.45%	-372.91%	-53.95%	101.10%	-32.83%	729.19%
Return on Net Nonoperating Assets (RNNOA)	-2.29%	-0.14%	0.72%	-0.17%	-0.84%	6.02%	-4.31%	-0.97%	0.56%	1.10%	-32.61%
Return on Equity (ROE)	-31.46%	0.93%	0.17%	0.92%	0.15%	-12.17%	-0.62%	8.17%	8.64%	12.47%	-19.89%
Cash Return on Invested Capital (CROIC)	11.17%	3.04%	0.09%	-1.83%	-7.66%	-8.00%	-1.48%	3.14%	1.02%	12.31%	38.85%
Operating Return on Assets (OROA)	-17.04%	3.27%	3.91%	3.17%	2.24%	-12.39%	1.21%	5.88%	9.71%	11.40%	-48.18%
Return on Assets (ROA)	-19.57%	0.27%	1.24%	0.18%	-1.26%	2.57%	-7.09%	2.59%	5.30%	8.82%	-52.51%
Return on Common Equity (ROCE)	-31.46%	0.93%	0.17%	0.92%	0.15%	-12.17%	-0.62%	8.17%	8.64%	12.47%	-19.89%
Return on Equity Simple (ROE_SIMPLE)	-8.11%	0.00%	-6.67%	-7.83%	0.23%	0.00%	-2.60%	-1.34%	1.81%	0.00%	-21.48%
Net Operating Profit after Tax (NOPAT)	-92	3.69	-1.77	3.89	3.12	-62	11	30	26	37	34
NOPAT Margin	-36.57%	1.34%	-0.67%	1.32%	1.09%	-19.86%	3.86%	9.56%	8.29%	11.38%	10.74%
Net Nonoperating Expense Percent (NNEP)	33.11%	7.07%	-48.48%	4.89%	23.69%	-449.63%	376.60%	63.10%	-93.02%	44.19%	-716.47%
Return On Investment Capital (ROIC_SIMPLE)	-	0.21%	-	-	-	-3.30%	-	-	-	1.88%	2.05%
Cost of Revenue to Revenue	32.34%	33.24%	33.91%	30.18%	29.47%	38.68%	29.68%	31.30%	29.19%	31.84%	30.32%
SG&A Expenses to Revenue	45.38%	43.51%	47.12%	42.83%	47.11%	42.99%	44.03%	40.53%	41.39%	42.14%	42.19%
R&D to Revenue	14.14%	16.35%	18.98%	17.40%	16.27%	14.89%	15.48%	14.04%	15.34%	13.46%	11.95%
Operating Expenses to Revenue	119.91%	61.69%	66.98%	63.91%	68.97%	89.69%	64.81%	56.09%	59.61%	56.66%	54.33%
Earnings before Interest and Taxes (EBIT)	-93	20	23	20	13	-79	7.18	37	60	72	-300
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-75	40	43	40	33	-58	25	55	79	91	-280
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.37	2.46	1.90	2.23	2.33	2.18	2.47	2.39	2.18	1.90	2.06
Price to Tangible Book Value (P/TBV)	68.71	42.30	26.28	26.60	25.73	11.94	15.42	13.02	10.19	7.55	59.65
Price to Revenue (P/Rev)	2.67	2.91	2.23	2.55	2.55	2.42	2.55	2.45	2.30	2.01	1.67
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	993.49	158.86	0.00	0.00	120.46	39.77	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.10%	0.63%	0.00%	0.00%	0.83%	2.51%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.33	2.43	1.89	2.18	2.27	2.17	2.46	2.40	2.22	1.98	2.19
Enterprise Value to Revenue (EV/Rev)	2.71	2.93	2.25	2.60	2.60	2.42	2.55	2.45	2.27	1.93	1.59
Enterprise Value to EBITDA (EV/EBITDA)	73.62	57.40	37.45	59.34	18.69	48.60	76.49	54.09	27.88	9.69	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	38.18	0.00	0.00	0.00	108.42	13.68	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	566.21	0.00	0.00	0.00	994.51	26.17	17.92
Enterprise Value to Operating Cash Flow (EV/OCF)	32.49	42.88	36.29	49.30	73.22	37.32	47.20	23.60	17.77	13.21	10.28
Enterprise Value to Free Cash Flow (EV/FCFF)	19.32	77.00	2,079.96	0.00	0.00	0.00	0.00	74.59	215.32	15.65	4.84
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.47	0.45	0.44	0.47	0.48	0.46	0.51	0.50	0.48	0.48	0.61
Long-Term Debt to Equity	0.45	0.43	0.42	0.46	0.46	0.45	0.50	0.49	0.46	0.42	0.53
Financial Leverage	0.04	0.02	0.02	0.04	0.04	0.01	0.01	0.02	0.01	-0.03	-0.04
Leverage Ratio	1.80	1.80	1.87	1.85	1.91	1.90	1.94	1.93	1.91	1.90	2.22
Compound Leverage Factor	2.04	0.58	0.79	0.49	-0.29	2.28	-9.25	1.12	1.41	1.49	2.34
Debt to Total Capital	32.01%	30.96%	30.65%	32.12%	32.39%	31.47%	33.83%	33.47%	32.34%	32.22%	37.81%
Short-Term Debt to Total Capital	1.29%	1.34%	1.26%	1.04%	1.05%	0.97%	1.07%	1.06%	1.13%	4.00%	4.78%
Long-Term Debt to Total Capital	30.72%	29.62%	29.39%	31.08%	31.34%	30.50%	32.76%	32.42%	31.21%	28.22%	33.02%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	67.99%	69.04%	69.35%	67.88%	67.61%	68.53%	66.17%	66.53%	67.66%	67.78%	62.19%
Debt to EBITDA	14.44	10.37	8.63	12.36	3.78	10.20	15.78	11.42	6.21	2.51	-11.30
Net Debt to EBITDA	0.90	0.50	0.31	1.11	0.35	0.15	0.22	-0.15	-0.40	-0.38	1.97
Long-Term Debt to EBITDA	13.86	9.92	8.28	11.96	3.66	9.88	15.28	11.06	5.99	2.20	-9.87
Debt to NOPAT	-11.69	-10.08	-8.75	-8.14	114.50	-12.24	-17.87	-32.93	221.44	6.79	5.56
Net Debt to NOPAT	-0.73	-0.48	-0.32	-0.73	10.62	-0.18	-0.25	0.42	-14.26	-1.04	-0.97
Long-Term Debt to NOPAT	-11.22	-9.64	-8.39	-7.88	110.79	-11.86	-17.31	-31.89	213.68	5.95	4.86
Altman Z-Score	1.53	1.82	1.51	1.75	1.80	1.59	1.73	1.81	1.82	1.71	0.48
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.96	2.98	2.86	3.27	3.23	2.95	3.17	3.45	3.37	2.87	1.58
Quick Ratio	1.40	1.34	1.24	1.42	1.43	1.44	1.58	1.75	1.68	1.59	1.27
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	96	96	61	52	-96	-114	28	89	37	99	340
Operating Cash Flow to CapEx	589.94%	204.76%	270.10%	-316.96%	208.03%	417.66%	156.00%	356.66%	281.01%	756.36%	222.11%
Free Cash Flow to Firm to Interest Expense	7.60	7.21	4.57	3.50	-6.42	-7.33	0.68	5.74	2.31	6.26	22.22
Operating Cash Flow to Interest Expense	2.81	1.40	1.54	-1.21	1.21	3.45	0.24	2.79	3.21	4.99	1.57
Operating Cash Flow Less CapEx to Interest Expense	2.34	0.72	0.97	-1.59	0.63	2.63	0.09	2.01	2.07	4.33	0.86
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.45	0.44	0.46	0.49	0.49	0.50	0.50	0.51	0.51	0.51
Accounts Receivable Turnover	5.74	5.55	5.80	5.98	6.18	5.79	6.11	6.26	6.42	6.14	6.20
Inventory Turnover	2.37	2.67	2.58	2.55	2.49	2.76	2.57	2.52	2.47	2.59	2.55
Fixed Asset Turnover	6.97	6.88	7.04	7.41	7.75	7.66	7.87	7.87	7.79	7.73	7.73
Accounts Payable Turnover	4.49	4.42	4.44	4.60	5.34	4.93	5.02	4.91	5.69	5.08	4.78
Days Sales Outstanding (DSO)	63.54	65.81	62.94	61.04	59.07	63.00	59.71	58.35	56.88	59.44	58.89
Days Inventory Outstanding (DIO)	153.80	136.46	141.36	143.41	146.33	132.36	141.80	145.05	147.72	140.94	143.34
Days Payable Outstanding (DPO)	81.26	82.56	82.22	79.31	68.32	74.07	72.75	74.37	64.17	71.83	76.33
Cash Conversion Cycle (CCC)	136.08	119.71	122.08	125.14	137.08	121.29	128.76	129.03	140.42	128.55	125.89
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,181	1,234	1,247	1,293	1,280	1,286	1,230	1,235	1,270	1,224	925
Invested Capital Turnover	0.80	0.80	0.82	0.82	0.91	0.92	0.96	0.96	0.97	1.00	1.18
Increase / (Decrease) in Invested Capital	-189	-93	-63	-48	99	53	-17	-59	-10	-62	-306
Enterprise Value (EV)	2,752	2,999	2,354	2,818	2,904	2,796	3,027	2,961	2,812	2,419	2,025
Market Capitalization	2,719	2,973	2,334	2,765	2,849	2,787	3,018	2,969	2,853	2,515	2,135
Book Value per Share	$21.42	$22.56	$22.91	$23.07	$22.74	$23.72	$22.64	$22.95	$24.13	$24.31	$19.03
Tangible Book Value per Share	$0.74	$1.31	$1.66	$1.93	$2.06	$4.33	$3.63	$4.21	$5.16	$6.13	$0.66
Total Capital	1,687	1,749	1,770	1,828	1,813	1,864	1,846	1,868	1,936	1,948	1,663
Total Debt	540	542	542	587	587	587	624	625	626	628	629
Total Long-Term Debt	518	518	520	568	568	569	605	605	604	550	549
Net Debt	34	26	20	53	54	8.78	8.77	-7.95	-40	-96	-110
Capital Expenditures (CapEx)	6.04	9.13	7.69	5.66	8.72	13	6.40	12	18	10	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	79	97	86	138	145	93	116	130	124	90	-229
Debt-free Net Working Capital (DFNWC)	585	612	609	673	677	671	732	763	791	813	509
Net Working Capital (NWC)	563	589	587	654	658	653	712	744	769	735	430
Net Nonoperating Expense (NNE)	15	2.03	-9.14	2.74	10	-78	53	14	-6.57	-19	361
Net Nonoperating Obligations (NNO)	34	26	20	53	54	8.78	8.77	-7.95	-40	-96	-110
Total Depreciation and Amortization (D&A)	18	20	20	19	20	21	18	18	19	18	20
Debt-free, Cash-free Net Working Capital to Revenue	7.73%	9.45%	8.25%	12.76%	12.95%	8.10%	9.81%	10.77%	9.99%	7.14%	-17.98%
Debt-free Net Working Capital to Revenue	57.51%	59.91%	58.29%	62.02%	60.58%	58.19%	61.77%	63.11%	63.67%	64.87%	39.92%
Net Working Capital to Revenue	55.38%	57.62%	56.16%	60.26%	58.88%	56.62%	60.10%	61.48%	61.91%	58.64%	33.68%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.01)	$0.03	$0.14	$0.02	($0.14)	$0.31	($0.78)	$0.30	$0.61	$1.04	($6.01)
Adjusted Weighted Average Basic Shares Outstanding	53.53M	53.47M	53.62M	53.80M	53.99M	53.94M	54.01M	54.24M	54.35M	54.24M	54.42M
Adjusted Diluted Earnings per Share	($2.01)	$0.04	$0.14	$0.02	($0.14)	$0.30	($0.78)	$0.30	$0.60	$1.04	($6.01)
Adjusted Weighted Average Diluted Shares Outstanding	53.53M	53.47M	53.90M	53.98M	53.99M	54.21M	54.01M	54.59M	54.59M	54.57M	54.42M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.52M	53.56M	53.77M	53.88M	53.87M	53.96M	54.15M	54.30M	54.30M	54.35M	54.53M
Normalized Net Operating Profit after Tax (NOPAT)	-1.80	9.77	-1.77	12	3.12	-62	11	30	26	37	34
Normalized NOPAT Margin	-0.71%	3.56%	-0.67%	4.14%	1.09%	-19.86%	3.86%	9.56%	8.29%	11.38%	10.74%
Pre Tax Income Margin	-42.00%	2.33%	3.71%	1.80%	-0.69%	-30.41%	-11.60%	6.78%	13.97%	17.55%	-99.62%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-7.38	1.48	1.73	1.36	0.87	-5.04	0.17	2.39	3.80	4.58	-19.65
NOPAT to Interest Expense	-7.30	0.28	-0.13	0.26	0.21	-3.94	0.27	1.96	1.66	2.32	2.23
EBIT Less CapEx to Interest Expense	-7.86	0.79	1.16	0.97	0.29	-5.86	0.02	1.61	2.66	3.92	-20.36
NOPAT Less CapEx to Interest Expense	-7.77	-0.41	-0.70	-0.12	-0.37	-4.77	0.12	1.18	0.52	1.66	1.52
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-3.82%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	9.39%	0.00%

Key Financial Trends

In Q1 2025, LivaNova reported operating revenue of $316.9 million, up 7.4% year-over-year, and maintained a strong gross margin of 69.7%. Operating income increased to $48.6 million, and free cash flow to the firm was a healthy $339.7 million. However, the quarter was weighed down by a $364.3 million other expense, resulting in a net loss of $327.3 million and EPS of –$6.01. Below are the key takeaways:

Revenue growth of 7.44% YoY, reaching $316.9 million
Robust gross margin of 69.7%, up from 68.2% in Q4 2024
Operating income rose to $48.6 million (+31% Q/Q)
Free cash flow to firm of $339.7 million
Cash & equivalents balance strong at $738.4 million
Invested capital of $924.7 million, down 24% Q/Q
Moderate leverage with debt-to-capital at 37.8%
Net loss widened to $327.3 million, driven by a $364.3 million other expense
Diluted EPS fell to –$6.01 from +$1.04 in Q4 2024
Net cash from operations declined ~70% Q/Q to $23.9 million

06/21/25 03:51 AMAI Generated. May Contain Errors.

Frequently Asked Questions About LivaNova's Financials

When does LivaNova's fiscal year end?

According to the most recent income statement we have on file, LivaNova's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has LivaNova's net income changed over the last 2 years?

LivaNova's net income appears to be on a downward trend, with a most recent value of $63.23 million in 2024, falling from -$86.25 million in 2022. The previous period was $17.55 million in 2023. View LivaNova's forecast to see where analysts expect LivaNova to go next.

What is LivaNova's operating income?

LivaNova's total operating income in 2024 was $129.05 million, based on the following breakdown:

Total Gross Profit: $870.87 million
Total Operating Expenses: $741.82 million

How has LivaNova's revenue changed over the last 2 years?

Over the last 2 years, LivaNova's total revenue changed from $1.02 billion in 2022 to $1.25 billion in 2024, a change of 22.7%.

How much debt does LivaNova have?

LivaNova's total liabilities were at $1.19 billion at the end of 2024, a 3.0% increase from 2023, and a 9.1% increase since 2022.

How much cash does LivaNova have?

In the past 2 years, LivaNova's cash and equivalents has ranged from $214.17 million in 2022 to $428.86 million in 2024, and is currently $428.86 million as of their latest financial filing in 2024.

How has LivaNova's book value per share changed over the last 2 years?

Over the last 2 years, LivaNova's book value per share changed from 22.56 in 2022 to 24.31 in 2024, a change of 7.8%.

Related Companies

This page (NASDAQ:LIVN) was last updated on 6/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LivaNova (LIVN) Financials

Key Financial Trends

Frequently Asked Questions About LivaNova's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LivaNova (LIVN) Financials

Annual Income Statements for LivaNova

Quarterly Income Statements for LivaNova

Annual Cash Flow Statements for LivaNova

Quarterly Cash Flow Statements for LivaNova

Annual Balance Sheets for LivaNova

Quarterly Balance Sheets for LivaNova

Annual Metrics And Ratios for LivaNova

Quarterly Metrics And Ratios for LivaNova

Key Financial Trends

Frequently Asked Questions About LivaNova's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools